CELLE
LIVE

Serial Number

97305795

Owner

CRYO-CELL INTERNATIONAL, INC.

Attorney

Daniel R. Frijouf

Filing Date

Mar 10, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CELLE Trademark

Serial Number: 97305795

CELLE is a trademark filed by CRYO-CELL INTERNATIONAL, INC. on March 10, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

CRYO-CELL INTERNATIONAL, INC. (75 trademarks)

Albany, NY 12205

Entity Type: 03

Trademark Details

Filing Date

March 10, 2022

Registration Date

Not Registered

Published for Opposition

July 11, 2023

Goods & Services

Cell parts in the nature of exosomes for medical purposes; biological preparations comprising exosomes for the treatment of wounds, cancers and neurodegenerative, cardiovascular, hematological, inflammatory, autoimmune, pulmonary and orthopedic diseases; human blood for medical purposes; blood plasma; cord blood for medical purposes; stem cells for medical purposes

Biological preparations comprising exosomes for use in scientific research, industry and science; Biological preparations comprising exosomes for use in the manufacture of pharmaceuticals for treating wounds, cancers and neurodegenerative, cardiovascular, hematological, inflammatory, autoimmune, pulmonary and orthopedic diseases; human blood for scientific and medical research use; Cord blood for scientific and medical research use; Stem cells for research and scientific purposes

Medical services, namely, infusion therapy services; Medical services, namely, cord blood infusion services, stem cell infusion services; Medical services, namely, stem cell transplantation, stem cell therapy and stem cell treatment services; Blood, organ, and tissue bank services for human blood, human umbilical cord blood, human umbilical cord blood stem cells, mesenchymal stem cells, human menstrual stem cells, birth tissue, placentas and human tissue for medical, therapeutic, biotechnological, cosmetic and pharmaceutical use; collection and preservation of human blood, menstrual blood, and umbilical cord blood, for medical, therapeutic, biotechnological, cosmetic and pharmaceutical use; Collection of umbilical cord stem cells, mesenchymal stem cells, menstrual stem cells, birth tissue, placentas and human tissue for medical, therapeutic, biotechnological, cosmetic and pharmaceutical use

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 4 GRANTED
Sep 2, 2025 EX4G
SOU EXTENSION 4 FILED
Sep 2, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 2, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 4, 2025 EXRA
SOU EXTENSION 3 GRANTED
Mar 4, 2025 EX3G
SOU EXTENSION 3 FILED
Mar 4, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 4, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 28, 2024 EXRA
SOU EXTENSION 2 GRANTED
Oct 28, 2024 EX2G
SOU EXTENSION RECEIVED WITH TEAS PETITION
Oct 25, 2024 TPEX
NOTICE OF REVIVAL - E-MAILED
Oct 25, 2024 NREV
PETITION TO REVIVE-GRANTED
Oct 25, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Oct 25, 2024 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 7, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 7, 2024 ABN6
SOU EXTENSION 2 FILED
Sep 5, 2024 EXT2
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jun 13, 2024 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 12, 2024 AITU
SOU EXTENSION RECEIVED WITH TEAS PETITION
Apr 9, 2024 TPEX
NOTICE OF REVIVAL - E-MAILED
Apr 9, 2024 NREV
PETITION TO REVIVE-GRANTED
Apr 9, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Apr 9, 2024 PROA
TEAS PETITION TO REVIVE RECEIVED
Apr 9, 2024 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 8, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 8, 2024 ABN6
SOU EXTENSION 1 FILED
Mar 5, 2024 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 5, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 11, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 11, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 21, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 5, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 5, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 5, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 5, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 5, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 2, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 1, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 1, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 1, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 1, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 1, 2023 CNRT
EXAMINER'S AMENDMENT ENTERED
Feb 2, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 2, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 2, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 2, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 26, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 26, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 26, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 16, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 16, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 16, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 11, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 15, 2022 NWOS
NEW APPLICATION ENTERED
Mar 14, 2022 NWAP